Pharmafile Logo

Remtec Search

The specialist European Medical Device and Life Science recruitment company, working internationally to assist candidates and clients from across the world. Remtec offers 2 main services: Executive search and Contingency selection focusing on sales, marketing and technical roles. Our extensive experience, combined with proven processes, allows us to offer an unprecedented service to employers seeking top quality candidates and to candidates seeking top quality employers.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…

View Profile

Company Details

Remtec Search and Selection Ltd, Registered Office, Breaks House, Mill Court, Cambridge, CB22 5LD, United Kingdom
+44 (0)1223 550 860

 Latest Content from PMHub 

The Mission to Humanize Healthcare

Medical and scientific innovation are in a fast lane closely pursued by digital advances but their dynamism can mute a vital element of progressive healthcare – patient integration.

Implementation of Cost-Effectiveness Analysis in Japan’s Health Technology Assessment Process

Japan’s evolving approach to market access includes a formal cost-effectiveness analysis (CEA) requirement for certain new medicines and medical devices. Introduced as part of a broader health technology assessment (HTA)...

Designing with patients in mind: How to build more inclusive clinical trials

Press Releases | August 4, 2025 | Cuttsy + Cuttsy

Discover how patient-centred design transforms inclusive clinical trials. Learn to overcome trial recruitment challenges by listening to patients and creating studies that fit real lives.

Mastering Patient Recruitment: A Framework of Five Essential Strategies Developed Over 15 Years

Clinical trial patient recruitment and retention practices have significantly advanced over the last 15 years thanks to technological innovations and the rise of AI, shifting patient expectations and the increased,...

The Impact of AI on Clinical Trials: Four Key Benefits and Three Major Risks

Artificial intelligence (AI) in clinical research has the potential to accelerate patient access to new treatments by streamlining the drug development process and helping to generate more robust data, which...

Three Key Trends Shaping the Future of Clinical Trials

So far this year, we have witnessed several announcements that could have a major impact on the clinical trials market and our global health overall.

Advertising For Women’s Health: Breaking Taboos and Driving Change

Our strategist Stephanie Goley, MSc, PhD takes a fascinating look at how advertising is breaking down stigmas around areas of women's health such as menstruation and menopause - and helping...

Dave W. Miller interviewed by Paige McGarry on the unique challenges faced by biotech companies

HealthEconomics.com interviews David W. Miller, CEO of Genesis Research Group, to discuss the unique challenges faced by biotech companies in evidence generation, market access, and stakeholder engagement.

Digital Transformation in the NHS’s 10-Year Plan: Techno-Optimism and the Limits of Efficiency

Here, Evelyne Priestman (Senior Consultant – HEOR) and Mary Baker (Senior Medical Writer) at Petauri Evidence explore the National Health Service (NHS) in England’s newly unveiled 10-year plan through the...

Bridging the gap: Should pharma step up as public health campaign funding declines?

With the decline in UK public health campaign funding, we have explored the unique opportunity presented to the pharmaceutical industry to step forward and do more to support the nation’s...